Showing results (2941-2950 of 8,949) with videos related to
Sort By:
Pageof 895
Schizophrenia Research|February 23, 2010
Attribution bias in ultra-high risk for psychosis and first-episode schizophreniaSuk Kyoon An, Jee In Kang, Jin Young Park, et al.Schizophrenia Research|September 11, 2016
Cardiometabolic risk in first-episode schizophrenia (FES) patients with the earliest stages of both illness and antipsychotic treatmentDesheng Zhai, Taizhen Cui, Yahui Xu, et al.Schizophrenia Research|September 11, 2016
Improved individualized prediction of schizophrenia in subjects at familial high risk, based on neuroanatomical data, schizotypal and neurocognitive featuresEleni Zarogianni, Amos J Storkey, Eve C Johnstone, et al.Schizophrenia Research|September 4, 2016
Substance use in youth at risk for psychosisR Carney, A R Yung, G P Amminger, et al.Schizophrenia Research|September 6, 2016
Dopamine, fronto-striato-thalamic circuits and risk for psychosisOrwa Dandash, Christos Pantelis, Alex FornitoSchizophrenia Research|August 27, 2016
Anomalous Self-Experiences and positive symptoms are independently associated with emotion processing deficits in schizophreniaDavid C Cicero, Mallory J Klaunig, Christi L Trask, et al.Schizophrenia Research|June 1, 2017
Correlates and predictors of antipsychotic drug polypharmacy in real-life settings: Results from a nationwide cohort studyLeo Malandain, Florence Thibaut, Lamiae Grimaldi-Bensouda, et al.Schizophrenia Research|May 14, 2017
Comparing early signs and basic symptoms as methods for predicting psychotic relapse in clinical practiceEmily Eisner, Richard Drake, Fiona Lobban, et al.Schizophrenia Research|May 17, 2017
Cognitive and functional deficits in people with schizophrenia: Evidence for accelerated or exaggerated aging?Philip D Harvey, Jennifer B RosenthalSchizophrenia Research|September 24, 2016
Association between prefrontal N-acetylaspartate and insight in psychotic disordersDaouia I Larabi, Edith J Liemburg, Gerdina H M Pijnenborg, et al.Pageof 895